0000950170-23-067790 Sample Contracts

ARCA BIOPHARMA, INC. AMENDMENT TO RETENTION BONUS LETTER

Retention Bonus Letter • December 4th, 2023 • ARCA Biopharma, Inc. • In vitro & in vivo diagnostic substances • Colorado

• Contract Type
  Retention Bonus Letter
• Filed
  December 4th, 2023
• Company
  ARCA Biopharma, Inc.
• Industry
  In vitro & in vivo diagnostic substances
• Jurisdiction
  Colorado

This amendment (the “Amendment”) is entered into effective as of December 4, 2023 by and between C. Jeffrey Dekker (“Executive”) and ARCA biopharma, Inc. (the “Company,” and together with Executive, the “Parties”).